This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Potts, M. The myth of the male pill. Nature Med. 2, 398–399 (1996).
World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336, 955–959 (1990).
Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil. Steril. 65, 821–829 (1996).
Behre, H.M. et al. Potential of testosterone buciclate for male contraception: Endocrine differences between responders and non-responders. J. Clin. Endocrinol. Metab. 80, 2394–2403 (1995).
Bebb, R.A. et al. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach. J. Clin. Endocrinol. Metab. 81, 757–762 (1996).
Nieschlag, E. & Behre, H.M. Hormonal male contraception: Suppression of spermatogenesis with GnRH antagonists and testosterone. in Treatment with GnRH Analogs: Controversies and Perspectives (ed. Filicori, M.) (Parthenon, London, 1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nieschlag, E., Waites, G. A male contraceptive pill. Nat Med 2, 722 (1996). https://doi.org/10.1038/nm0796-722b
Published:
Issue date:
DOI: https://doi.org/10.1038/nm0796-722b